Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03262259 · ClinicalTrials.gov registry record · NA
Evaluation of Global Smart Drinking Goals Initiative
A NA study of Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms, sponsored by HB.
- Recruiting
- Registry status
- NA
- Development phase
- 36,000
- Enrollment target
- 1
- Study location
NCT03262259: Recruiting NA study of Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms, sponsored by HB.
NCT03262259 is a NA study of Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms that is actively recruiting participants, run by HB. The registered enrollment target is 36,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2466% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03262259, a NA study of Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms, is actively recruiting participants, sponsored by HB.
- RECRUITING
- Registry status
- NA
- Development phase
- 36,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate effects of a multi-component, population-level intervention on alcohol use and related harms in six intervention cities relative to six matched comparison cities. Intervention components include screening and brief interventions by health providers, other evidence-based interventions (e.g., enforcement of drink-driving or underage drinking laws), and novel or partially tested interventions that warrant further evaluation. Key outcomes of interest include alcohol-related harms such as alcohol-related motor vehicle crashes and fatalities, heavy/binge drinking, underage drinking, and drinking and driving.
Primary Outcome
Self-reported problems related to alcohol use (e.g., drinking and driving, injury, unwanted sex, vandalism, property crime); alcohol-related motor vehicle crashes and fatalities
Interventions
- BEHAVIORAL GSDG multi-component intervention
Study Locations (1)
Maryland
- HBSA - Calverton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36,000 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT03262259 shows while recruiting
NCT03262259 is an interventional study that assigns participants to a tested intervention. Its 36,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2466% higher).
The record links to 1 condition, with Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms appearing as the primary indexed condition, and to 1 intervention - of which GSDG multi-component intervention is the first listed.
NCT03262259 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03262259 about?
NCT03262259 is a clinical study titled "Evaluation of Global Smart Drinking Goals Initiative". This study will evaluate effects of a multi-component, population-level intervention on alcohol use and related harms in six intervention cities relative to six matched comparison cities. Intervention components include screening and brief interventions by health providers, other evidence-based inte...
What is the current status of trial NCT03262259?
This trial is currently recruiting. It is a NA study. The enrollment target is 36,000 participants. The study started on 2017-09-01. Estimated completion is 2025-12-31.
What conditions does trial NCT03262259 study?
This clinical trial studies the following conditions: Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms.
What interventions are being tested in trial NCT03262259?
The interventions under investigation include: GSDG multi-component intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03262259?
This trial is sponsored by HB, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03262259 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03262259's enrollment target sits among peer trials
36,000 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT05796505 · 37,122 participants · NA
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI